internal organs). Each domain generates a specific score and determines a sum that guides the treatment toward conser vative, palliative, and/or excisional. The proportion of pa tients who have sufficient data for the TSS (to determine utility until the decisionmaking) 12, 13 is unknown.
OBjECTIvE
To evaluate the percentage of patients with sufficient data to apply TSS prediction to treatment decision making.
METhOdS
Patients with a known or suspected diagnosis of spinal me tastases who were consecutively admitted to the Hospital do Servidor Público Estadual de São Paulo (HSPE) were eva luated with the TSS from July 2010 to January 2012. The pro ject was approved by the Research and Ethics Committee of HSPE.
The patients received complete neurological examina tions, and the Frankel scale and the following TSS items were collected (if available) until therapeutic decisions were made: neurological and general clinical condition (as described on the KS), the number of bony extra-spinal metastases (mea sured with skeletal scintigraphy with Technetium-99), the number of metastases in the vertebral bodies (measured by a neuroaxis magnetic resonance image [MRI] of the entire spine and/or scintigraphy of the skeleton), the number of me tastases in important internal organs (measured by a chest and abdominal computed tomography [CT[ scan), breast and gynecological evaluations, and a specific search for the primary cancer sites.
The decision making consisted of performing surgery, ra diotherapy or biopsy.
Statistics
The numerical data are described as mean±standard de viation. The categorical data are presented as percenta ges. Student' s ttests were used for the paired and unpaired groups as appropriate. The significance level was established as p<0.05.
RESULTS
Sixty spinal metastasis patients were evaluated from July 2010 to January 2012. Of these patients, 21 were female and 39 were male. The average age was 60.52±11.69 for women and 63.20±10.54 for men. There was no statistically signifi cant difference between the ages of the groups (p>0.05).
Among the 60 patients, only 2 were asymptomatic, both of whom were referred from the oncology department after an active search for metastasis. Eighteen patients presented with spinal pain: 23 because of neurological deficits and 17 because of both pain and neurological deficits.
Only 15 patients (25%) completely fulfilled the TSS. All of the patients were neurologically (Frankel scale) and clinically (KS) evaluated. Neurologically, 6 patients presented with complete deficit (Frankel A), 3 with Frankel B, 23 with Frankel C, 12 with Frankel D, and 16 with Frankel E (Figure 2 ).
The KS in our sample varied from 30 to 90. Three patients (5%) presented with a KS of 30, 7 patients with 40, 13 patients with 50, 19 patients with 60, 6 patients with 70, 6 patients with 80, and 5 patients with 90 ( Figure 3 ).
Fifteen of the 60 patients (25%) were evaluated with bone scintigraphy. All 15 showed spinal uptake; 5 of these patients presented with diffuse skeletal uptake; and 3 presented with skull, sternum, and rib uptake.
Until the therapeutic decision was made, no patient was given an entire neuroaxis MRI evaluation due to time constraints and MRI availability. In contrast, all of the patients underwent local spine MRIs directed at the spinal cord com pression site.
In this study, 78% of spinal metastases were localized in the thoracic spine, 41% in the lumbar spine, 13% in the cervi cal spine, and 10% in the sacral spine.
Before the treatment decision was made, only 25% of pa tients had undergone bone scintigraph y, 30% had received thoracic and abdominal tomography, and no patient had a complete spine MRI evaluation.
In the search for metastases in important internal organs, only 18 patients were evaluated by a thoracic or abdominal CT scan. In five of these cases, only diffuse lymphadenopathy was noted; pulmonary nodules were observed in four cases, liver metastasis in three, and pleural thickening in one.
Thirty-nine of the 60 (65%) patients had received a histo pathological diagnosis prior to admission. Of these diagnoses, 11 were in the breast, 11 were in the prostate, and 5 were in the lung; 4 patients had multiple myeloma, 3 had colon cancer, and 2 had non-Hodgkin' s lymphoma. Bladder, kidney, and larynx cancer were reported by one patient each (Figu re 4) .
The TSS was not completely fulfilled in 75% of patients (Table) ; rather, the decisions concerning conservative, pallia tive, and excisional treatment were based on clinical, neuro logical, and imaging data.
Fifty-five percent of patients were treated conservatively with radiotherapy; 33% underwent a decompressiononly ap proach, decompression was added to a spine fixation in 5%, 4% only underwent a diagnostic percutaneous biopsy, and an an terior decompression approach was used in 3% of cases.
dISCUSSION
The TSS is a tool used to determine survival prognosis. The extent and complexity of disease management depends on the patient's prognosis and life expectancy; patients with life expectancies less than 6 months are treated conserva tively or with palliative surgery, a life expectancy of 6 to 12 months involves palliative surgery, and the expectation for patients with a life expectancy greater than 12 months is ex cision surgery 12, 13 . Prognostic prediction scales should be based on accessi ble data. Metastatic disease is a predictor of poor outcome in cancer patients; in particular, metastatic disease has a high potential of mortality, morbidity, and definitive neurological deficits, such as paraplegia and paraparesis. Time is the main factor involved; delayed clinical or surgical treatments may generate irreversible neurological deficits 7 . In our sample, most of the patients who sought treatment for symptomatic spinal metastases presented with few neu rological deficits, and they were healthy enough for surgery.
A full evaluation of all the TSS variables requires sophisti cated imaging diagnostic tools with expensive, complex, time consuming, and not always readily available sources. Only a quarter of our patients were able to completely satisfy the re quirements for the TSS before the decision-making process. Many other systems to predict the prognosis and guide de cision making are available, such as the Sioutos, Tomita, Van der Linden, and Bauer scores. The TSS has been the most wide ly accepted and used scoring system, and it has significant pre dictive value [14] [15] [16] [17] [18] . However, every score, even with its particu larities, requires complete evaluation of the systemic disease, including a histological diagnosis. Several authors have demonstrated that the primary tumor site is the most important prog nostic factor for patient survival, and this is well accepted 19 . However, in vertebral metastasis with spinal cord compres sion, there is an urgent need for decisionmaking, and the histo logical diagnosis and tumor staging data require time that is not available before treatment 7 . The histological diagnosis of prima ry cancer requires a prior sample for analysis, sample fixation, slide preparation, staining, and immunohistochemical analysis for a definitive diagnosis. This could take 2 to 5 days using stan dard services. A bone scintigraphy study protocol also demands several hours for completion. CT scans of the vital organs and MRI require fasting time and the availability of equipment.
Although the apparatuses for diagnosis are present in the study hospital, clinical and neurological conditions and the specific protocols of radiological studies do not allow for full patient assessment before surgery. Furthermore, complete evaluations sometimes require the use of more than one device, which undoubtedly dramatically increases the time required to complete the tests.
The urgent treatment of vertebral metastasis still remains paramount to protect spinal cord vitality 1, 2, 6, 8, 11, [14] [15] [16] [17] . Cancer staging data were absent in the majority of our cases until the moment of therapeutic intervention in the spinal cord compression cases.
Thus, some authors maintain that the surgical decision cri teria should be based on clinical and neurological disor ders instead of prognostic scales 1, 20 . Our results support those views. Although diagnostic equipment was available, the neu rological status associated with patient health is urgent, and the multiplicity of required tests prevents complete fulfillment of the TSS before making a treatment decision. To our knowledge, the applicability of the TSS in clinical conditions outside research protocols has not been previously evaluated in the li terature. Therefore, our reasoning appears to be a novelty.
CONCLUSIONS
In the majority of patients with vertebral metastasis, TSS variables were incomplete, and the system was not useful in guiding treatment types.
